Molecular Detection Inc. Launches Improved Detect-Ready® MRSA Panel
Comparative data confirming the greater accuracy of the Detect-Ready MRSA panel was generated by researchers at St. Thomas' Hospital in London as part of an academic study. The study compared the performance of MDI's test and the Becton Dickinson GeneOhm MRSA PCR sold by BD Diagnostics. The researchers concluded that the Detect-Ready MRSA assay is superior to the GeneOhm panel in terms of specificity, while still providing a more rapid screening service compared to traditional microbiology culture methods.*
Detect-Ready kits are compatible with a number of the real time-PCR platforms currently found in most hospitals. Samples for testing are simple to obtain using nasal swabs and the kit's ready-to-use pre-mixed reagents require only the addition of patient sample to run the test, which provides results in less than three hours. Unlike other tests that require special handling, Detect-Ready kits are off-the-shelf room temperature-stabilized and require no refrigeration.
The Detect-Ready MRSA Panel is currently available in the UK, Germany, Ireland, Switzerland, Spain, Austria, the Netherlands, Belgium, Luxembourg, Australia and Israel, and is in late-stage development in the US.
Tags: Sample Preparation, Swabs, MRSA, Staphylococcus aureus, PCR, Pathogen, Staphylococcus
Date Published: April 3, 2012
Source article link: Molecular Detection » company contact details
Efficacy of MWE’s Liquid Medium Transport Swabs on BioFire FilmArray® Platform
InnovaPrep Launches New Generation Concentrating Pipette
Bruker Acquires MERLIN Adding Speciality AST and ART
New ABL Semi-Micro Balances Weigh to 5 Places with GLP Printouts
Leading Food Hygiene Lab Reports on the Inlabtec Serial Diluter